| Serial Number | 97648862 |
| Word Mark | ADDS |
| Filing Date | Wednesday, October 26, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, April 17, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development in the fields of pharmaceuticals, therapeutics, and biologics, namely, exosome-based delivery systems for pharmaceuticals, therapeutics, and biologics; Medical research and development in the field of molecular biology, genetic engineering, drug delivery, and bioinformatics; Research and development of delivery systems for therapeutic compounds, namely, exosome-based drug delivery systems for therapeutic compounds for the treatment of viral pathogens, cancer and inherited disorder in humans; Research and development of delivery systems for therapeutic compounds, namely, exosome-based drug delivery of therapeutic compounds; Research and development of delivery systems for therapeutic nucleic acids, namely, exosome-based drug delivery of therapeutic nucleic acids, namely, RNA; Research and development of delivery systems for therapeutic peptides, namely, exosome-based drug delivery of therapeutic peptides; Research and development of delivery systems for gene-editing proteins, namely, exosome-based drug delivery of gene-editing proteins; Research and development of delivery systems for vaccines, namely, exosome-based drug delivery systems for vaccines; Research and development of delivery systems for vaccines, namely, exosome-based drug delivery systems for pharmaceutical compounds; Research and development of the production of exosomes for therapeutic uses, namely, yeast-based exosome for therapeutic uses; Research and development of new biological products for therapeutic use; Design and development of nucleic acids, proteins, enzymes, and drug compounds for use in pharmaceuticals, biotechnology, medical, and diagnostic applications |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 31, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, October 26, 2022 |
| First Use In Commerce Date | Wednesday, October 26, 2022 |
| Party Name | Spartina Biotechnologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Santa Fe, NM 87507 |
| Event Date | Event Description |
| Monday, April 17, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, April 17, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, April 17, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, December 30, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 30, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, December 30, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, December 15, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, October 29, 2022 | NEW APPLICATION ENTERED |